miRNA Multiplayers in glioma. From bench to bedside.

作者: Katarzyna Rolle

DOI: 10.18388/ABP.2015_1072

关键词:

摘要: Glioblastoma multiforme (GBM) is the most common type of malignant gliomas, characterized by genetic instability, intratumoral histopathological variability and unpredictable clinical behavior. Disappointing results in treatment gliomas with surgery, radiation chemotherapy have fuelled a search for new therapeutic targets modalities. A novel small non-coding RNA molecules, microRNAs (miRNAs), appear to represent one attractive target molecules contributing pathogenesis various types tumors. They play crucial roles tumorigenesis, angiogenesis, invasion apoptosis. Some miRNAs are also associated outcome chemo- radiotherapy resistance. Moreover, miRNA potential affect responses molecular-targeted therapies they might be cancer stem cell properties, affecting tumor maintenance progression. The expression profiles useful subclassification GBM, what underscores heterogeneity diseases that all share same WHO grade. Importantly, molecular subtypes GBM correlate phenotypes, characteristic outcomes. then biological markers possible diagnostic prognostic potential. could serve as promising human glioblastoma.

参考文章(117)
David E. Gerber, Targeted therapies: a new generation of cancer treatments. American Family Physician. ,vol. 77, pp. 311- 319 ,(2008)
Eliza Wyszko, Katarzyna Rolle, Stanislaw Nowak, Ryszard Zukiel, Monika Nowak, Rafał Piestrzeniewicz, Iwona Gawrońska, Mirosława Z Barciszewska, Jan Barciszewski, None, A multivariate analysis of patients with brain tumors treated with ATN-RNA. Acta Poloniae Pharmaceutica. ,vol. 65, pp. 677- 684 ,(2008)
Ronald Koschny, Thomas Koschny, Ursula G Froster, Wolfgang Krupp, Margit A Zuber, Comparative genomic hybridization in glioma: a meta-analysis of 509 cases Cancer Genetics and Cytogenetics. ,vol. 135, pp. 147- 159 ,(2002) , 10.1016/S0165-4608(01)00650-1
Stefan Michelfelder, Martin Trepel, Adeno-Associated Viral Vectors and Their Redirection to Cell-Type Specific Receptors Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part A. ,vol. 67, pp. 29- 60 ,(2009) , 10.1016/S0065-2660(09)67002-4
Paul Kleihues, David N. Louis, Bernd W. Scheithauer, Lucy B. Rorke, Guido Reifenberger, Peter C. Burger, Webster K. Cavenee, The WHO Classification of Tumors of the Nervous System Journal of Neuropathology and Experimental Neurology. ,vol. 61, pp. 215- 225 ,(2002) , 10.1093/JNEN/61.3.215
JIRI POLIVKA, VLADIMIR ROHAN, ONDREJ TOPOLCAN, JIRI FERDA, None, New Molecularly Targeted Therapies for Glioblastoma Multiforme Anticancer Research. ,vol. 32, pp. 2935- 2946 ,(2012)
Dvora Nass, Shai Rosenwald, Eti Meiri, Shlomit Gilad, Hilla Tabibian-Keissar, Anat Schlosberg, Hagit Kuker, Netta Sion-Vardy, Ana Tobar, Oleg Kharenko, Einat Sitbon, Gila Lithwick Yanai, Eran Elyakim, Hila Cholakh, Hadas Gibori, Yael Spector, Zvi Bentwich, Iris Barshack, Nitzan Rosenfeld, MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors Brain Pathology. ,vol. 19, pp. 375- 383 ,(2009) , 10.1111/J.1750-3639.2008.00184.X
Takashi Sasayama, Masamitsu Nishihara, Takeshi Kondoh, Kohkichi Hosoda, Eiji Kohmura, MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. International Journal of Cancer. ,vol. 125, pp. 1407- 1413 ,(2009) , 10.1002/IJC.24522
Witold Filipowicz, Suvendra N. Bhattacharyya, Nahum Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics. ,vol. 9, pp. 102- 114 ,(2008) , 10.1038/NRG2290